Recognizing and Addressing the Public's Knowledge Gaps Concerning Aducanumab and Alzheimer Disease
- PMID: 35157062
- DOI: 10.1001/jamanetworkopen.2021.48361
Recognizing and Addressing the Public's Knowledge Gaps Concerning Aducanumab and Alzheimer Disease
Comment on
-
Knowledge and Attitudes Concerning Aducanumab Among Older Americans After FDA Approval for Treatment of Alzheimer Disease.JAMA Netw Open. 2022 Feb 1;5(2):e2148355. doi: 10.1001/jamanetworkopen.2021.48355. JAMA Netw Open. 2022. PMID: 35157058 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical